Trial Profile
Tenofovir for the treatment of breakthrough hepatitis caused by lamivudine and adefovir dipivoxil-resistant mutants of hepatitis B virus
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2012
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 10 Oct 2012 New trial record